Self-medication for migraine: A nationwide cross-sectional study in Italy

PLoS One. 2019 Jan 23;14(1):e0211191. doi: 10.1371/journal.pone.0211191. eCollection 2019.

Abstract

Headache disorders are considered the second leading cause of years lived with disability worldwide, and 90% of people have a headache episode at least once a year, thus representing a relevant public health priority. As the pharmacist is often the first and only point of reference for people complaining of headache, we carried out a survey in a nationwide sample of Italian pharmacies, in order to describe the distribution of migraine or non-migraine type headaches and medicines overuse among people entering pharmacies seeking for self-medication; and to evaluate the association, in particular of migraine, with socio-demographic and clinical characteristics, and with the pathway of care followed by the patients. A 14-item questionnaire, including socio-demographic and clinical factors, was administered by trained pharmacists to subjects who entered a pharmacy requesting self-medication for a headache attack. The ID Migraine™ Screener was used to classify headache sufferers in four classes. From June 2016 to January 2017, 4424 people have been interviewed. The prevalence of definite migraines was 40%, significantly higher among women and less educated people. About half of all headache sufferers and a third of migraineurs do not consider their condition as a disease and are not cared by any doctor. Among people seeking self-medication in pharmacies for acute headache attacks, the rate of definite or probable migraine is high, and a large percentage of them is not correctly diagnosed and treated. The pharmacy can be a valuable observatory for the study of headaches, and the first important step to improve the quality of care delivered to these patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cross-Sectional Studies
  • Female
  • Humans
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Migraine Disorders* / drug therapy
  • Migraine Disorders* / epidemiology
  • Pharmacies*
  • Pharmacists*
  • Prevalence
  • Self Medication*
  • Sex Factors
  • Socioeconomic Factors
  • Surveys and Questionnaires*

Grants and funding

The authors declare that this study was funded by FOFI, Federation of the Orders of Italian Pharmacists, Rome, Italy. The source of the funding had no role in the design of the study or the analysis and interpretation of the data. The role of the Federation was solely to verify that the study had been conducted in accordance with the agreed methodology.